Hayat Pharmaceutical Industries Co. Ltd.

Hayat Pharmaceutical Industries Co. has recently experienced a score revision, influenced by various market trends and metrics. In the latest quarter, the company reported a decline in net sales and profit, alongside challenges in managing receivables, while still maintaining a positive return on equity and stock performance over the past year.

Hayat Pharmaceutical Industries Co. has experienced a recent evaluation adjustment, reflecting changes in its financial metrics and market position. The company reported flat financial results for the quarter ending June 2025, with declines in net sales and profit, while maintaining a positive return on equity.